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Introduction
Determining whether a soft tissue mass is benign or
malignant is vital for appropriate management. Radio-
graphs can determine if prominent fat or calcification
is present, but are otherwise rather limited in usefulness.
Computed tomography (CT) scans depict anatomic
detail but are insufficient to determine the histology,
unless the lesion is pure fat or simple fluid.1 Conse-
quently, magnetic resonance imaging (MRI) is the
modality of choice for the preoperative evaluation of
soft-tissue lesions.2 Its superior soft-tissue contrast and
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ability to depict anatomic relationship between mass
and surrounding structures have led some to believe
that it may be a reliable method to determine if soft
tissue lesions are benign or not. However, the results
have so far been less than ideal and inconsistent.3–6
Most of these prior studies relied on various levels of
morphologic analysis. The presence of specific tissue
characteristics such as fibrous tissue, calcification and
myxoid tissue in soft tissue masses were reported but
not analyzed for its value in differentiating benign from
malignant soft tissue lesions.7–9 Hence, the purpose
of this study was to evaluate both tissue typing and
morphologic MRI features in distinguishing between
benign and malignant soft tissue masses.
Methods
Patients and reference standard
A total of 132 soft masses examined over a 4-year
period were retrospectively reviewed. Fourteen cases
were excluded because of inadequate pathologic con-
firmation (n = 2) or recurrence (n = 12). Consequently,
MRI features of 118 masses (56 benign and 62 malig-
nant lesions) in 118 patients (male:female ratio, 53:
65; age range, 5–87 years; mean age, 47 years) were
included.
MRI techniques
All scans were obtained on a 1.5-T Signa Excite (GE
Healthcare, Milwaukee, WI, USA) or a 1.5-T Mag-
netom Vision (Siemens Medical Solutions, Erlangen,
Germany). All studies included at least 1 T1-weighted
sequence (TR/TE = 400–700/14–30), 1 T2-weighted
sequence (TR/TE = 1,800–2,500/54–100) and 1 fat-
saturated sequence or short tau inversion recovery
(STIR) sequence, and were imaged in at least 2 orthog-
onal planes. Section thickness ranged from 3 mm to
5 mm. Field of view and use of body or surface coils
varied according to the size and location of the lesions.
Gadolinium (Gd-DTPA) enhancement was used in all
but 2 patients in this series.
Image analysis and interpretation
The images from MRI were retrospectively reviewed
by 2 musculoskeletal radiologists (C.K. Chen and
H.T. Wu) who had no previous knowledge of the
pathologic diagnosis. Discrepancies in interpretation
were decided by consensus. Nineteen parameters classi-
fied into 2 groups were analyzed. Elements of Group
1 were different tissue characteristics including: (1)
high T1 matrix; (2) low T2 matrix; (3) fibrous tissue;
(4) calcification; (5) myxoid tissue; (6) fatty tissue;
(7) cyst; (8) necrosis; (9) septations; (10) vascular signal
void signal; (11) fat rim; and (12) hemorrhage.
High T1 matrix was defined by presence of high
signal foci on T1-weighted images (WI); low T2
matrix indicated low signal foci in T2WI. Myxoid tissue
showed lobulated (patchy geographic) areas with low
to high signal on T1WI and very high signal on T2WI
(very high signal area in T2WI having intervening
curvilinear low signal).8 Fat revealed very high signal
intensity on T1WI, moderately high signal intensity
on T2WI, and low signal intensity on fat-suppressed
images or STIR images.10 Fibrous tissue had low signal
intensity on both T1WI and T2WI, and demonstrated
delayed contrast enhancement after post gadolinium
contrast injection.11,12 Calcification demonstrated very
low signal or signal void both on T1 and T2WI.13 Cyst
showed regular margin, and round or oval morphology,
with low signal intensity on T1WI and high signal
intensity on T2WI. Necrosis appeared as areas with low
signal intensity on T1WI, low to high signal intensity
on T2WI and without post-contrast enhancement.
Septations were considered lines that transversed the
lesion and divided it into lobules.14 Vessels were tubular
or serpiginous structures with flow voids with and
contrast enhancement.15 A fat rim was defined as pe-
ripheral rim of high signal, isointense to fat signal on
T1WI at the margin of the mass.16 Hemorrhage was
considered present if there was high signal intensity
on T1WI with low or high signal intensity on T2WI,
which did not drop on fat-suppressed images.17
Elements of Group 2 were traditional morphologic
and perilesional change parameters that included: (1)
maximal diameter of lesion in transverse section (in cm);
(2) lesion depth in longitudinal section (in cm); (3)
margins: well-versus ill-defined; (4) peritumoral edema;
(5) bone involvement; (6) marginal capsule or pseudo-
capsule; and (7) neurovascular bundle involvement.
Edema was defined as infiltrative, feathery areas of
high signal intensity surrounding the mass on T2WI.18
Bone involvement was shown if the mass lesion attached
or eroded the cortex of neighboring bone. Presence
of capsule or pseudocapsule was defined as a linear
low signal, both on T1WI and T2WI, delineating the
margin of a mass from adjacent tissue.19,20 Neurovas-
cular bundle involvement or invasion by the lesion
was also recorded.
Each parameter of the mass lesion, as described
above, was recorded as present, absent or undetermined.
Statistical analysis
Univariate analyses were tested using the χ2 test. The
frequency distribution of the individual MRI parameters
in the benign group was compared with that in the
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malignant group. A p value of less than 0.05 was con-
sidered to be statistically significant. The predictive
value of 3 different models built by different combina-
tions of parameters was determined by logistic regres-
sion. The best combination of MRI parameters that
predicted malignancy by back-stepping procedure was
selected to build Model 1. Model 2 consisted of 7 mor-
phologic and perilesional change parameters. Model 3
consisted of 12 component-characterizing parameters.
The sensitivity, specificity, positive and negative pre-
dictive values, and accuracy of each model were calcu-
lated, as the cut-off value of predictive probability of
parameters was set at 0.5 by default. Parameters assigned
“undetermined” were not included in the analyses.
Data analyses were performed using SPSS version
13.0 (SPSS Inc., Chicago, IL, USA).
Results
Diagnosis
The final diagnoses of the 118 soft tissue masses are
listed in Table 1. There were 56 benign masses and
62 malignant ones. The average age for benign lesions
was 46 years and that for malignant lesions was 49
years (p = 0.49). Neurogenic tumor, hemangioma and
fibromatosis were among the most common benign
soft tissue masses. Liposarcoma, malignant fibrous
histiocytoma, synovial sarcoma and leiomyosarcoma
comprised 56% (35/62) of the malignant lesions.
Regarding the body part distribution of the 56 benign
masses, 11 (20%) were in the upper arms, 8 (14%)
were in the thighs, 7 (13%) were in the lower legs, 
6 (11%) were in the knees, 4 (7%) were in the feet, 
3 (5%) each were in the shoulders, ankles and pelvis, 
2 each were in the lower legs, elbows and chest wall,
and 1 each were in the abdominal wall and inguinal,
forearm, wrist and back regions. Of the 62 malignant
lesions, 31 (50%) were in the thighs, 6 (10%) were in
the pelvis, 5 (8%) were in the knees; 3 (5%) each were in
the lower legs and arms, 2 (3%) each were in the elbows,
forearms, feet, ankles and wrists, and 1 (2%) each were
in the shoulder, inguinal, buttock and back regions.
Frequency distribution of individual MRI
parameters
Table 2 lists the results of univariate analysis. The size
(> 5 cm), maximal depth (> 8 cm), presence of T2 low
signal matrix, fibrous tissue (Figure 1), calcification
(Figure 2), necrosis (Figure 3), fat rim sign (Figure 4),
septum, perifocal edema, and hemorrhage showed
statistically significant differences between benign and
malignant lesions. The sensitivity, specificity, positive
and negative predictive values of individual MRI param-
eters are listed in Table 3. There were several situa-
tions tabulated as indeterminate, including 8 in fibrous
tissue, 5 in myxoid tissue, 2 each in cyst, necrosis, 
vessels and fat rim, and 1 each in peritumoral edema
and fat.
Combination of MRI parameters
After excluding 17 cases that contained at least 1 un-
determined parameter, 101 cases were used to build
models for predicting malignancy of soft tissue masses.
Logistic regression showed that the best combination of
parameters in predicting malignancy was fibrous tissue,
Table 1. Summary of 118 soft tissue masses listed by histologic
diagnosis
Diagnosis n
Benign mass (n = 56)
Neurogenic tumor 18
Hemangioma 10
Fibromatosis 5
Lipoma 4
Tumoral calcinosis 2
Pigmented villonodular synovitis 2
Myositis ossifications 2
Epidermal cyst 2
Fibroma 2
Chondroma, soft tissue 1
Myxoma 1
TB granuloma 1
Neuroma 1
Hematoma, organizing 1
Angiofibroma 1
Xanthogranulomatous inflammation 1
Angiomyoma 1
Hemophilic pseudotumor 1
Malignant mass (n = 62)
Liposarcoma 17
Malignant fibrous histiocytoma 6
Synovial sarcoma 6
Leiomyosarcoma 6
Sarcoma, undifferentiated 4
Metastasis, carcinoma 4
Alveolar soft tissue part sarcoma 4
Squamous cell carcinoma 2
Chondrosarcoma, extraskeletal 2
Clear cell sarcoma 2
Spindle cell tumor, low grade 1
Pigmented villonodular synovitis, malignant 1
Lymphoma, panniculitis type 1
Leukemia 1
Hemangiopericytoma 1
Ewing’s sarcoma, extraskeletal 1
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calcification, necrosis, a fat rim, peritumoral edema and
maximal mass diameter (Model 1). The combination
of these parameters resulted in the most correct diag-
noses, with a sensitivity of 84.2%, specificity of 64.0%,
and accuracy of 74.8%. Model 2 yielded sensitivity of
64.5%, specificity of 78.2%, and accuracy of 70.9%.
Component characterizing imaging parameters (Model
3) had a sensitivity of 81.1%, specificity of 66.7%, and
accuracy of 74.3%. The Hosmer-Lemeshow goodness-
of-fit test showed no significant difference for each
model, indicating that all the models were adequately
fitted.
A B C D
Figure 1. Demonstration of fibrous tissue in histologically proven fibromatosis in a 47-year-old man who had a palpable mass for 
2 years. Reticulations (arrows) were of low signal intensity on: (A) coronal; and (B) sagittal T1-weighted images. (C) Low signal intensity
on coronal T2-weighted imaging with fat saturation. (D) Sagittal T1-weighted contrast-enhanced imaging showed minimal enhancement
(arrows).
Table 2. Summary of univariate analysis for distribution of component characterizing and traditional morphologic and perilesional change
parameters of MRI in benign and malignant soft tissue masses*
MRI features Benign (n = 56) Malignant (n = 62) p
Component characterizing parameters
T1 high signal matrix 17 (30) 27 (43) 0.09
T2 low signal matrix 23 (41) 9 (14) 0.001†
Myxoid 10 (18) 11 (19) 0.986
Fat 11 (20) 14 (23) 0.663
Fibrous 15 (29) 7 (12) 0.028†
Calcification 6 (11) 0 (0) 0.008†
Cyst 5 (9) 9 (15) 0.386
Necrosis 5 (9) 28 (46) < 0.001†
Septations 23 (41) 38 (61) 0.028†
Vessels 9 (17) 11 (18) 0.878
Hemorrhage 7 (13) 18 (29) 0.032†
Fat rim sign 12 (22) 3 (5) 0.007†
Traditional morphologic & perilesional change parameters
Size > 5 cm 12 (21) 37 (60) < 0.001†
Maximal depth > 8 cm 15 (27) 37 (60) < 0.001†
Margin: ill-defined 31 (55) 48 (77) 0.11
Peritumoral edema 35 (64) 55 (89) 0.001†
Bone involvement 14 (25) 22 (36) 0.217
Capsule 16 (29) 17 (27) 0.889
Neurovascular bundle involvement 15 (27) 23 (37) 0.231
*Data presented as n (%); †p < 0.05.
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Discussion
Soft tissue is derived from mesenchyma and consists of
skeletal muscle, fat, fibrous tissue, vascular structures
and peripheral nervous system.21 Soft tissue masses
include various disease entities, including inflamma-
tory, traumatic/vascular, and neoplastic (benign and
malignant) conditions. The precise diagnosis of a specific
A B
C
Figure 2. Demonstration of calcification deposition in pathologi-
cally proven tumoral calcinosis in a 32-year-old man with a painful
right buttock mass for 6 months. Magnetic resonance imaging 
of the pelvis showed: (A) low signal area (arrowheads) on axial T1-
weighted imaging; (B) very low signal (arrowheads) on axial T2-
weighted imaging; (C) without contrast enhancement (arrowheads)
on post-contrast axial T1-weighted imaging with fat saturation.
A B C
Figure 3. Demonstration of necrosis in pathologically proven leiomyosarcoma in a 79-year-old woman with painful swelling of the right
thigh for 3 months. (A) Low signal region on coronal T1-weighted imaging (arrow); and (B) high density on coronal T2-weighted imaging
(arrow) were suggestive of necrosis. (C) In post-contrast coronal T1-weighted imaging, the lesion revealed peripheral enhancement
(arrow). Non-necrotic solid tissue part (arrowheads) was also seen.
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soft tissue mass is generally established by biopsy.22
Even a history of a rapid growth rate or specific physical
examination findings are not useful in discriminating
between benign and malignant soft tissue masses,1,23
hence the theoretical appeal of MRI. However, the pub-
lished opinions about the ability of individual specific
MRI morphologic characteristics to discriminate be-
tween benign and malignant masses have been less
than stellar.3,4,24,25
In the univariate analysis part of this study, 11
individual parameters that had significantly different
associations with benign or malignant lesions had po-
tential application. Most of these involved tissue char-
acterization. Among these 11 parameters, necrosis had
the highest specificity (90.9%) and positive predictive
value (84.8%) for malignant mass, which was consistent
with the studies of De Schepper et al26 and van Rijswijk
et al.27 The parameters with third highest specificity
were hemorrhage and large lesion size (> 5 cm). Param-
eters having the highest sensitivity for malignancy were
absence of calcification (100.0%), fat rim (95.1%), and
peritumoral edema (88.7%).
In the combination study, we found that morphol-
ogic and perilesional change parameters (Model 2) had
the lowest differentiating capability, which was com-
parable with the study by van Rijswijk et al.27 Com-
ponent characterizing imaging parameters (Model 3)
showed better sensitivity than morphologic and per-
ilesional change parameters. The best combination of
parameters favoring malignancy was lesion size > 5 cm,
peritumoral edema, necrosis, absent calcification, ab-
sent fibrosis, and lack of fat rim. This result demon-
strated 4 component characterizing parameters in 6
parameters.
The value of intravenous contrast in the evaluation
of soft tissue masses is controversial.28–31 In the cur-
rent study, contrast helped to characterize tissues,
such as myxoid, cyst and necrosis, which in turn had
discriminatory power between benign and malignant
lesions.
A B
C
Figure 4. Demonstration of fat rim sign in benign neurogenic
tumor in the arm of a 61-year-old woman. Magnetic resonance
imaging showed the cystic nodule: (A) surrounded by high signal
rim on axial T1-weighted imaging (arrowheads); and (B) moderate
high signal on axial T2-weighted imaging (arrowheads), suggestive
of fat signal. (C) Contrast-enhanced axial T1 imaging with fat satu-
ration demonstrated that the signal of the rim was suppressed
(arrowheads), and there was another inner contrast-enhancing
rim, which was found to be the cellular component of the tumor on
histologic examination (arrows).
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We acknowledge several limitations to this study.
First, including more benign lesions means that more
lesions with specific MRI appearance (e.g. lipoma, neu-
rogenic tumor, hemangioma, ganglion cyst) can be diag-
nosed and hence increase sensitivity and specificity in
differentiation of benign versus malignant lesions.17
In the current study, we had relatively more malignant
lesions (n = 62) than benign lesions (n = 56). The sen-
sitivity and specificity of our model and individual
parameters were lower than those of previous studies
with higher percentages of benign lesions,3,4,17,23,24,26
but similar to those of studies with a comparable ratio
of benign lesions.27 Second, using parameters and
models to predict malignancy of soft tissue masses on
certain benign lesions having characteristic appearance
that is readily diagnosed by MRI can produce false-
positive or false-negative results. In our study, 2 of 8
readily diagnosed hemangiomas would be thought to be
malignant by the predicting models since they showed
peritumoral edema, contained no calcification or fibro-
sis, and were > 5 cm. Also, 2 of 19 neurogenic tumors
had necroses which were highly suggestive of their
malignancy. On the other hand, 1 of 11 liposarcomas
that were easily diagnosed would have been regarded as
a benign lesion since it demonstrated no necrosis, no
peritumoral edema, no hemorrhage, and no septation.
Third, the MRI “component characterizing” patterns
were based on reported signal characteristics rather
than actual histologic assessment. Further study may
be needed to correlate these imaging patterns with his-
tologic specimens. Fourth, interpretations were made
in consensus and not independently.
In conclusion, pattern recognition of component
characteristics of soft tissue masses can increase the
ability of MRI to differentiate benign and malignant
soft tissue masses. It has advantage over traditional
morphologic and perilesional analysis; however, a com-
bination of these characteristics yields the best results.
The parameters favoring malignancy were large lesion
size, peritumoral edema, necrosis, and absent fat rim,
absent calcification, and lack of fibrosis.
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